Therefore, future studies conducted over an optimal period are needed to validate the data presented in this research and to accurately evaluate the impact of GLP-1 analogs on liver function in patients with T2DM and MASLD. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.